[HTML][HTML] Management of metabolic-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: from medication therapy to nutritional …

M Beygi, S Ahi, S Zolghadri, A Stanek - Nutrients, 2024 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a common long-lasting liver disease that affects
millions of people around the world. It is best identified with a hepatic fat build-up that …

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

XD Zhou, G Targher, CD Byrne, V Somers… - Hepatology …, 2023 - Springer
Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …

The role of punicalagin and its metabolites in atherosclerosis and risk factors associated with the disease

S Alalawi, F Albalawi, DP Ramji - International journal of molecular …, 2023 - mdpi.com
Atherosclerotic cardiovascular disease (ACVD) is the leading cause of death worldwide.
Although current therapies, such as statins, have led to a marked reduction in morbidity and …

Management of residual risk in chronic coronary syndromes. Clinical pathways for a quality-based secondary prevention

S Giubilato, F Lucà, MG Abrignani, L Gatto… - Journal of Clinical …, 2023 - mdpi.com
Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical
presentations of coronary artery disease (CAD), is the leading cause of morbidity and …

Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues

J Baj, B Kowalska, A Barbachowska, A Forma… - Nutrients, 2023 - mdpi.com
Dyslipidaemia is a disorder of the lipid metabolism, caused mainly by poor eating habits.
The most severe consequence of an inappropriate diet is the development of …

Interaction between non-alcoholic fatty liver disease and obesity on the risk of develo** cardiovascular diseases

X Wang, J You, J Tang, X Li, R Wang, Y Li, Y Bai… - Scientific Reports, 2024 - nature.com
Backgrounds This investigation seeks to explore the correlation between nonalcoholic fatty
liver disease (NAFLD) and cardiovascular diseases (CVDs), and to to provide evidence for …

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance

MA Robea, IM Balmus, I Girleanu, L Huiban, C Muzica… - Medicina, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Its
incidence is progressively rising and it is possibly becoming a worldwide epidemic. NAFLD …

Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis

S Shea, C Lionis, C Kite, L Lagojda… - Frontiers in …, 2024 - frontiersin.org
Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
affecting 25-30% of the general population globally. The condition is even more prevalent in …

[HTML][HTML] Relationship between atherogenic dyslipidemia and lipid triad with scales that assess non alcoholic liver disease in 418,343 spanish workers

JIR Manent, PT Gil, JLC Villalonga, PM Lliteras… - Academic Journal of …, 2023 - enfispo.es
Relationship between atherogenic dyslipidemia and lipid triad with scales that assess non
alcoholic liver disease in 418,343 spanish workers - Enfispo Enfispo Buscar Revistas Tesis …

Insight into the inter-organ crosstalk and prognostic role of liver-derived micrornas in metabolic disease progression

BS Goncalves, A Meadows, DG Pereira, R Puri… - Biomedicines, 2023 - mdpi.com
Dysfunctional hepatic metabolism has been linked to numerous diseases, including non-
alcoholic fatty liver disease, the most common chronic liver disorder worldwide, which can …